Beyond Antibodies: Vaccines Teach T-Cells to Fight COVID Long Term
[ad_1] FRIDAY, Jan. 28, 2022 COVID-19 vaccines activate long-lasting immune system T-cells that target coronavirus variants of concern, including Delta and Omicron, new research shows. The research team at the La Jolla Institute for Immunology in California studied adults who were fully vaccinated with the Pfizer, Moderna, Johnson & Johnson or Novavax vaccines, but had […]
Read More